Mucin 16 (MUC16)—also called carcinoma antigen 125 (CA125)—is arguably the most consistently used biomarker for ovarian cancer [58, 59, 61, 64, 72, 73, 211, 214–221]. This evidence concerns the gene MUC16 and ovarian carcinoma.